SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Investors are expressing frustration over a sharp sell-off in Oracle shares despite a strong earnings report, with many pointing to options expiration and institutional selling as the primary drivers of the volatility. Debate continues regarding the company's debt levels and capital expenditures, while some traders view the price dip as an attractive entry point for the long term.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

The stock declined as a surge of negative sentiment and high volume on social media fueled concerns over a third-party statistical model that revised the odds of success for the company's ongoing Phase 3 trial. Traders remain divided, with many dismissing the move as a coordinated short attack and temporary volatility driven by stop-loss harvesting rather than any fundamental change in the clinical outlook.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is trending as investors discuss ongoing infrastructure developments and speculation surrounding potential institutional partnerships and the acquisition of Chain. While some traders express optimism regarding the project's long-term utility and neobank integration, others remain highly skeptical, frequently labeling the recent price action as a pump-and-dump scheme.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin shares are seeing significant volatility as traders debate whether the stock is undergoing institutional accumulation or being systematically manipulated by market makers, leading to frequent intraday reversals despite strong fundamentals. While many investors remain bullish due to the company's high profit margins and potential for growth in the e-commerce advertising space, the stock's inability to hold gains during broader market rallies has sparked significant frustration and debate over the impact of short-term algorithmic trading and analyst price target revisions.

the cat on Base  community-run home for $BASECAT

Basecat

Basecat is experiencing significant price volatility following its recent listing on Coinbase, with traders debating whether the current decline represents a typical "pump and dump" cycle or a buying opportunity. While some community members view the pullback as a chance to accumulate, others express skepticism about the token's long-term sustainability as a meme asset.

Alliance Entertainment Holding Corp. engages in the distribution of music, movies, and consumer electronics. It distributes its physical media, entertainment products, hardware, and accessories through an established multi-channel strategy. The company was founded in 1990 and is headquartered in Plantation, FL.

Alliance Entertainment Holding Corporation - Ordinary Shares - Class A

AENT is experiencing high volatility as traders debate the impact of the company's low-float structure and recent earnings results, with many expressing frustration over persistent downward price pressure and the influence of short sellers. Investors remain divided, with some highlighting the company's profitable operations and pivot to collectibles as reasons for long-term optimism, while others remain skeptical due to the lack of trading volume and recent governance developments.

Amplify Commodity Trust - Breakwave Tanker Shipping ETF

Breakwave Tanker Shipping ETF

The Breakwave Tanker Shipping ETF is trending due to surging tanker freight rates driven by geopolitical instability in the Strait of Hormuz and Red Sea, which has significantly increased transport costs and shipping distances. The community is actively debating the fund's extreme volatility and long-term viability, with many traders viewing it as a high-stakes play on oil shipping disruptions while others express skepticism about its sustainability.

RTX Corp. is an aerospace and defense company, which engages in the provision of aerospace and defense systems and services for commercial, military, and government customers. It operates through the following segments: Collins Aerospace Systems (Collins), Pratt and Whitney, Raytheon Intelligence and Space (RIS), and Raytheon Missiles and Defense (RMD). The Collins segment manufactures and sells aero structures, avionics, interiors, mechanical systems, mission systems, and power controls. The Pratt and Whitney segment includes the design and manufacture of aircraft engines and auxiliary power systems for commercial, military, and business aircraft. The RIS segment is involved in the development of sensors, training, and cyber and software solutions. The RMD segment offers end-to-end solutions to detect, track, and engage threats. The company was founded in 1922 and is headquartered in Arlington, VA.

RTX Corp

Raytheon Technologies Corporation

RTX is trending as traders react to a pullback in defense stocks despite a strong financial performance and a record backlog. Market sentiment remains divided, with some investors viewing the price decline as a buying opportunity given the company's role in global munitions replenishment, while others express frustration over the recent downward momentum.

Hunter Biden’s Laptop (LAPTOP) is a memecoin referencing the eponymous Hunter Biden laptop sensation that’s been a fixture in global media news cycles for the past six years. LAPTOP is a fungible, freely transferable, non-yield-bearing ERC-20 token on Base. As a memecoin, LAPTOP has no utility, but incorporates two novel distribution mechanics designed to promote long-term community growth: a large community airdrop and an event-based supply mechanism.

Hunter Biden's Laptop

The community is focused on a sharp, rapid decline in the token's value shortly after its launch, with many traders labeling the event a "rug pull" and expressing skepticism over the project's legitimacy. Opinions are highly polarized, ranging from mockery of those who suffered losses to speculation about potential future volatility or further price depreciation.

Himax Technologies, Inc. is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The company's products include display drivers, timing controllers, wafer level optics, video and display technology solutions, liquid crystal over silicon silicon, complementary metal-oxide semiconductor image sensor, and power integrated circuit. Its products used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, car navigation, virtual reality (VR) devices and many other consumer electronics devices. Himax Technologies was founded by Biing Seng Wu and Jordan Wu on June 12, 2001 and is headquartered in Tainan, Taiwan.

Himax Technologies - ADR

Himax Technologies, Inc.

HIMX is trending as investors react to volatility in the semiconductor sector and debate the impact of reports concerning potential delays in co-packaged optics (CPO) production. While some traders view the recent price pullback as a consolidation phase or buying opportunity, others are expressing caution regarding broader market macro factors and options expiration volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Innate Pharma to Host Conference Call and Webcast on September 17 for First Half 2026 Financial Results and Business Update

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (Innate or the Company), today announced that the Company will hold a conference call on Thursday, September 17, 2026 at 2:00 p.m. CEST / 8:00 a.m. EDT, to provide a business update for the first half of 2026. Participants in the...

Innate Pharma to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (Innate or the Company), a clinical-stage biotechnology company developing immunotherapies for cancer patients, today announced that members of its executive team will participate in a fireside chat and one-on-one investor...

Innate Pharma Announces Conference Call and Webcast

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (Innate or the Company), today announces that the Company will hold a conference call on Friday, August 14, 2026 at 2:00 p.m. CEST / 8:00 a.m. EDT. Participants during the call will be: Jonathan Dickinson, Chief Executive Officer...

Innate Pharma Jumps as Sobi Deal Boosts Secured Financing for Advancing Rare Skin Cancer Therapy

Sobi and Innate Pharma partner for a Phase 3 trial of lacutamab targeting rare skin cancer, featuring a $75 million upfront payment.read more...

Innate Pharma Lands Major Lacutamab Lifeline as Phase 3 Push Accelerates

Innate Pharma (NASDAQ:IPHA) is entering a potentially pivotal new chapter after announcing plans to advance lacutamab toward the TELLOMAK-3 Phase 3 study following its strategic partnership with Sobi. The deal provides a significant financial catalyst at a critical point in development, with Innate expecting a $75 million upfront payment upon closing and additional near-term development milestones. The company says the proceeds are intended to support TELLOMAK-3 and a planned filing for accelerated approval of lacutamab in Sézary syndrome, while extending its projected cash runway through the third quarter of 2027.

Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma

Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma PR Newswire STOCKHOLM, Aug. 10, 2026 STOCKHOLM, Aug. 10, 2026 /PRNewswire/ -- Swedish OrphanBiovitrum AB (publ...

Innate Pharma to Advance Lacutamab Towards Phase 3 Following Partnership With Sobi and Appoints New Chief Medical Officer

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (Innate or the Company) today announced that, subject to the closing of its strategic partnership with Sobi, it plans to initiate the TELLOMAK-3 confirmatory Phase 3 study of lacutamab in cutaneous T-cell lymphoma (CTCL). Innate...

Innate Pharma Enters Strategic Partnership With Sobi to License Lacutamab in T-cell Lymphoma

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") and Swedish Orphan Biovitrum AB (publ) (Sobi) today announced that they have entered a strategic partnership to enable initiation of the TELLOMAK-3 confirmatory Phase 3 study in cutaneous T-cell...

Innate Pharma to Participate in a Bladder Cancer Panel at the BTIG Virtual Biotechnology Conference

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (Innate or the Company), a clinical-stage biotechnology company developing immunotherapies for cancer patients, today announced that Sonia Quaratino, EVP Chief Medical Officer of Innate Pharma, will participate in the panel...

Innate Pharma Announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-drug Conjugate (ADC)

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company"), today announced the completion of enrollment in the dose escalation of the Phase 1 study of IPH4502 (NCT06781983), its proprietary Nectin-4 exatecan ADC. Preliminary data are expected by year-end and...

Innate Pharma SA is a global, clinical-stage biotechnology company, which engages in developing immunotherapies for cancer patients. Its product pipeline includes Lacutamab, Monalizumab, Avdoralimab, and IPH62. The company was founded by Hervé Eloi Dominique Brailly, Eric Vivier, Marc Bonneville, Alessandro Moretta, Jean-Jacques Fournié, and François Romagné on September 23, 1999 and is headquartered in Marseille, France.

Innate Pharma - ADR

IPHA Stock Soars Pre-Market After FDA Clears Late-Stage Trial For Lacutamab In Rare Skin Cancers

Equity

Bearish Sentiment

President Trump has promised to issue a $5,000 "dividend" check to every adult American citizen if the Republican Party wins control of both the House and the Senate in the upcoming midterm elections, though the proposal would require congressional approval and follows his earlier $2,000 tariff-dividend plan, which stalled after the Supreme Court struck down much of his tariff authority. Do you think the $5,000 dividend check actually happens? Vote and explain your reasoning in the comments.

Trump has pledged a $5,000 &quot;dividend&quot; check to every adult American citizen if Republicans win control of both the House and Senate in the midterms. Do you think it actually happens?

Stocktwits

Trump has pledged a $5,000 "dividend" check to every adult American citizen if Republicans win control of both the House and Senate in the midterms. Do you think it actually happens?

Current Price	$1.87
Prev Close	$1.88
Open	$1.89
Dividend Yield	0.00%
50-Day Moving Average	$1.96
Beta	0.63
Avg. Volume	405,893.40
PE Ratio	-3.04

52-Week High	$2.71
52-Week Low	$1.17
Market Capitalization	$208.88M
EPS (Annual)	-$0.6195
Price to Book	-6.87
Revenue Per Employee	$19,296.61

Feed

News

Sentiment

Earnings

Fundamentals

Info

IPHA Fundamentals